Clinical Trial Update: SCLC on the 2nd Line With Relapsed After Response to Chemotherapy GFPC 01-2013 [Phase 3]

View source ↗

Summary

Phase 3 clinical trial GFPC 01-2013 evaluating second-line therapy for small cell lung cancer that relapsed after chemotherapy; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Snippet

Sponsor: University Hospital, Angers | Conditions: Small Cell Lung Cancer | Phase 3 | Status: UNKNOWN